Long-term clinical outcomes and risk factors for the occurrence of post-operative complications after cardiovascular surgery in patients with Behçet's disease

Clinical and Experimental Rheumatology

Volumn 30, Issue SUPPL.72, 2012, Pages

  Ha, You Jung ^a   Jung, Sang Youn ^b   Lee, Kwang Hoon ^a   Jung, Se Jin ^a   Lee, Sang Won ^a   Park, Min Chan ^a   Lee, Soo Kon ^a   Shim, Won Heum ^a   Chang, Byung Chul ^a   Park, Yong Beom ^a  

^a Yonsei University College of Medicine   (South Korea)

^b CHA Bundang Medical Center   (South Korea)

Author keywords

Beh et's disease; Cardiovascular surgery; Immunosuppression

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; GLUCOCORTICOID; MESALAZINE; PREDNISOLONE; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ANASTOMOSIS LEAKAGE; ANEURYSM RUPTURE; AORTA ANEURYSM; AORTA VALVE REGURGITATION; ARTICLE; BEHCET DISEASE; CARDIOVASCULAR SURGERY; CLINICAL ARTICLE; CLINICAL FEATURE; DOSE RESPONSE; DRUG MEGADOSE; DRUG WITHDRAWAL; EBSTEIN ANOMALY; FALSE ANEURYSM; FEMALE; GRAFT FAILURE; HEART FAILURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LEUKOPENIA; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; SURGICAL MORTALITY; SURGICAL PATIENT; SURGICAL RISK; SURVIVAL RATE; SURVIVAL TIME; TOXIC HEPATITIS; TREATMENT OUTCOME; TRICUSPID VALVE REGURGITATION; CARDIOVASCULAR DISEASE; HEART SURGERY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; TIME; VASCULAR SURGERY;

ADULT; BEHCET SYNDROME; CARDIAC SURGICAL PROCEDURES; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 84873244487     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. BEHÇET H. üüber residivierende, aphtöse durch ein virus verursachtes Geschwüre am Mund, am Auge und an der Genitalien. Derm Wschr 1937; 105: 1152-7.
2. ONDER M, GURER MA. The multiple faces of Behcet's disease and its aetiological factors. J Eur Acad Dermatol Venereol 2001; 15: 126-36.
3. SEZEN Y, BUYUKHATIPOGLU H, KUCUKDURMAZ Z, GEYIK R. Cardiovascular involvement in Behçet's disease. Clin Rheumatol 2010; 29: 7-12.
4. YAZICI H, ESEN F. Mortality in Behçet's syndrome. Clin Exp Rheumatol 2008; 26 (Suppl. 50): S138-40.
5. ALPAGUT U, UGURLUCAN M, DAYIOGLU E. Major arterial involvement and review of Behçet's disease. Ann Vasc Surg 2007; 21: 232-9.
6. SCHNEIDER F, GOUNY P, VAN LAERE O, DUEDAL V, NUSSAUME O. Vascular complications after surgical repair of aneurysms in Behçet's disease. J Cardiovasc Surg (Torino) 2002; 43: 501-5.
7. OZEREN M, MAVIOGLU I, DOGAN OV, YUCEL E. Reoperation results of arterial involvement in Behçet's disease. Eur J Vasc Endovasc Surg 2000; 20: 512-9.
8. ANDO M, KOSAKAI Y, OKITA Y, NAKANO K, KITAMURA S. Surgical treatment of Behçet's disease involving aortic regurgitation. Ann Thorac Surg 1999; 68: 2136-40.
9. BRADBURY AW, MILNE AA, MURIE JA. Surgical aspects of Behçet's disease. Br J Surg 1994; 81: 1712-21.
10. AHN JK, KIM H, LEE J et al. Treatment outcomes in patients with non-infectious aortic valvulitis undergoing aortic valve replacement: implication for the treatment of aortic valve involvement in Behçet's disease. Rheumatol Int 2009; 29: 1391-3.
11. SUZUKI KUROKAWA M, SUZUKI N. Behçet's disease. Clin Exp Med 2004; 4: 10-20.
12. THE INTERNATIONAL STUDY GROUP FOR BEHÇET'S DISEASE: Evaluation of diagnostic ('classification') criteria in Behçet's disease - towards internationally agreed criteria. The International Study Group for Behçet's disease. Br J Rheumatol 1992; 31: 299-308.
13. JEONG DS, KIM KH, KIM JS, AHN H. Longterm experience of surgical treatment for aortic regurgitation attributable to Behçet's disease. Ann Thorac Surg 2009; 87: 1775-82.
14. PARK MC, HONG BK, KWON HM, HONG YS. Surgical outcomes and risk factors for postoperative complications in patients with Behçet's disease. Clin Rheumatol 2007; 26: 1475-80.
15. KALKO Y, BASARAN M, AYDIN U, KAFA U, BASARANOGLU G, YASAR T. The surgical treatment of arterial aneurysms in Behçet disease: a report of 16 patients. J Vasc Surg 2005; 42: 673-7.
16. HOSAKA A, MIYATA T, SHIGEMATSU H et al. Long-term outcome after surgical treatment of arterial lesions in Behçet disease. J Vasc Surg 2005; 42: 116-21.
17. KO Y, GLL I, AKPEK G et al. Vascular involvement in Behçet's disease. J Rheumatol 1992; 19: 402-10.
18. CHANG HK, LEE SS, BAI HJ et al. Validation of the classification criteria commonly used in Korea and a modified set of preliminary criteria for Behçet's disease: a multi-center study. Clin Exp Rheumatol 2004; 22 (Suppl. 34): S21-S6.
19. IDEGUCHI H, SUDA A, TAKENO M et al. Neurological manifestations of Behçet's disease in Japan: a study of 54 patients. J Neurol 2010; 257: 1012-20.
20. CHO YH, JUNG J, LEE KH, BANG D, LEE ES, LEE S. Clinical features of patients with Behçet's disease and epididymitis. J Urol 2003; 170: 1231-3.
21. ISCAN ZH, VURAL KM, BAYAZIT M. Compelling nature of arterial manifestations in Behçet disease. J Vasc Surg 2005; 41: 53-8.
22. OKADA K, EISHI K, TAKAMOTO S et al. Surgical management of Behçet's aortitis: a report of eight patients. Ann Thorac Surg 1997; 64: 116-9.
23. LĚ THI HUONG D, WECHSLER B, PAPO T et al. Arterial lesions in Behçet's disease. A study in 25 patients. J Rheumatol 1995; 22: 2103-13.
24. LEE I, PARK S, HWANG I et al. Cardiac Behçet disease presenting as aortic valvulitis/ aortitis or right heart inflammatory mass: a clinicopathologic study of 12 cases. Am J Surg Pathol 2008; 32: 390-8.
25. SHEN LL, CUI GG, LIANG RL. Valve prolapse in Behçet's disease. Br Heart J 1985; 54: 100-1.
26. TAI YT, FONG PC, NG WF et al. Diffuse aortitis complicating Behçet's disease leading to severe aortic regurgitation. Cardiology 1991; 79: 156-60.
27. MOTOMURA N, KAWAZOE K, KITO H, EISHI K, KAWASHIMA Y, OKA T. Application of cryopreserved allograft to aortic root replacement for valve detachment case due to aortitis. Nihon Kyobu Geka Gakkai Zasshi 1993; 41: 1426-30.
28. SCHIRMER M, CALAMIA KT, ODUFFY JD. Is there a place for large vessel disease in the diagnostic criteria of Behçet's disease? J Rheumatol 1999; 26: 2511-2.
29. GOLDEN BD, GOEL A, MITNICK HJ. Behçet-type vasculopathy in a patient without the diagnostic features of Behçet's disease. Arthritis Rheum 1996; 39: 1926-30.
30. DI EUSANIO G, MAZZOLA A, GREGORINI R et al. Left ventricular aneurysm secondary to Behçet's disease. Ann Thorac Surg 1991; 51: 131-2.
31. HUTCHISON SJ, BELCH JJ. Behçet's syndrome presenting as myocardial infarction with impaired blood fibrinolysis. Br Heart J 1984; 52: 686-7.
32. MÜFTÜOǦLU AU, YAZICI H, YURDAKUL S et al. Behçet's disease. Relation of serum Creactive protein and erythrocyte sedimentation rates to disease activity. Int J Dermatol 1986; 25: 235-9.
33. SUGIMOTO T, MIYASHITA M, OTA T, YAMASHITA C, OKADA M, NAKAMURA K. Surgical treatment of valvular heart disease associated with Behçet's disease. Nippon Kyobu Geka Gakkai Zasshi 1990; 38: 2320-5.
34. HAMURYUDAN V, OZYAZGAN Y, HIZLI N et al. Azathioprine in Behçet's syndrome: effects on long-term prognosis. Arthritis Rheum 1997; 40: 769-74.
35. BOSCH X, GUILABERT A, ESPINOSA G, MIRAPEIX E. Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review. JAMA 2007; 298: 655-69.